新光药业：2025年前三季度净利润约4534万元

Group 1 - The core point of the article is that New Light Pharmaceutical (SZ 300519) reported its Q3 performance, showing a revenue decline but an increase in net profit and earnings per share [1] Group 2 - For the first three quarters of 2025, the company's revenue was approximately 206 million yuan, a year-on-year decrease of 4.9% [1] - The net profit attributable to shareholders was about 45.34 million yuan, reflecting a year-on-year increase of 19.99% [1] - The basic earnings per share were 0.28 yuan, which is a year-on-year increase of 16.67% [1] Group 3 - As of the report date, New Light Pharmaceutical's market capitalization was 2.6 billion yuan [2]